TELETRADER News
2/28, 12:28 AM (Source: TeleTrader)
more TeleTrader news

FDA approves J&J's COVID-19 vaccine for emergency use

The United States Food and Drug Administration (FDA) approved the coronavirus vaccine developed by Johnson & Johnson for emergency use, making it the third jab with such designation in the US.

FDA's advisory board recommended the jab for the Emergency Use Authorization on Friday. The firm said earlier that it stands ready to deliver between 3 million and 4 million doses of its vaccine to the US inoculation centers, which is a bit more modest of a figure than the initially hinted 10 million. Johnson & Johnson's COVID jab makes the vaccination process somewhat less challenging than in the case of the vaccines made by Moderna or Pfizer, as it requires a single dose, and doesn't need to be stored at ultra-low temperatures.

"The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States," Acting FDA Commissioner Janet Woodcock commented.

Breaking the News / BU